---
$id: https://graph.org.ai/products/commodity/51302312
$type: Product
source: UNSPSC
code: "51302312"
title: "Eberconazole"
class: "51302300"
classTitle: "Antifungal imidazoles"
family: "51300000"
familyTitle: "Antifungal drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Eberconazole

**UNSPSC Code**: 51302312
**Class**: [Antifungal imidazoles](Antifungal imidazoles.mdx)
**Family**: [Antifungal drugs](../Antifungal drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antifungal agent with the molecular formula C18H14Cl2N2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier V7O1U41C9B, chemically known as (+-)-1-(2,4-dichloro-10,11-dihydro-5h-dibenzo(a,d)cyclohepten-5-yl)imidazole but generally known as eberconazole, which bears US NIH Compound Identifier 72051. European Medicines Agency schedules Eberconazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06436MIG. The term EBERCONAZOLE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 5, No. 3 1991, List 31). Most nations schedule eberconazole under HS 29332990 and SITC 51573. As of Q4 2014, EBERCONAZOLE remains the US FDA Preferred Term for this commodity. Eberconazole bears US NLM identifiers UMLS ID C0767000 and NCI Concept Code C72961. SMILES: CLC1C2C(N3CCNC3)C3C(CCC2CC(CL)C1)CCCC3.

